Get started
Author

Ilsa Coleman

Observed names: I Coleman, I. Coleman, Ilsa L. Coleman
ORCID: 0000-0002-1483-7202
Observed ORCID: 0000-0002-1483-7202
OpenAlex ID: A5056006386
The Gene Expression Program of Prostate Fibroblast Senescence Modulates Neoplastic Epithelial Cell Proliferation through Paracrine Mechanisms
2006 · Claes Bavik, Ilsa Coleman, et al. · Cancer Research · 453
IL-6 promotes prostate tumorigenesis and progression through autocrine cross-activation of IGF-IR
2011 · A Rojas, G Liu, et al. · Oncogene · 154
Supraphysiological androgens suppress prostate cancer growth through androgen receptor–mediated DNA damage
2019 · Payel Chatterjee, Michael T. Schweizer, et al. · Journal of Clinical Investigation · 109
PDF
Assessment of Androgen Receptor Splice Variant-7 as a Biomarker of Clinical Response in Castration-Sensitive Prostate Cancer
2022 · Adam G. Sowalsky, Ines Figueiredo, et al. · Clinical Cancer Research · 33
PDF
Characterization of an Abiraterone Ultraresponsive Phenotype in Castration-Resistant Prostate Cancer Patient-Derived Xenografts
2016 · Hung-Ming Lam, Ryan McMullin, et al. · Clinical Cancer Research · 29
Characterization of HOXB13 expression patterns in localized and metastatic castration‐resistant prostate cancer
2023 · Radhika A Patel, Erolcan Sayar, et al. · The Journal of Pathology · 25
PDF
Publisher Correction: The long tail of oncogenic drivers in prostate cancer
2019 · PCF/SU2C International Prostate Cancer Dream Team, Joshua Armenia, et al. · Nature Genetics · 14
Comprehensive Assessment of Anaplastic Lymphoma Kinase in Localized and Metastatic Prostate Cancer Reveals Targetable Alterations
2022 · Radhika A. Patel, Ilsa Coleman, et al. · Cancer Research Communications · 13
PROX1 is an early driver of lineage plasticity in prostate cancer
2025 · Zhi Duan, Mingchen Shi, et al. · Journal of Clinical Investigation · 11
The adult environment promotes the transcriptional maturation of human iPSC-derived muscle grafts
2024 · Sarah B. Crist, Karim Azzag, et al. · npj Regenerative Medicine · 7
PDF
Molecular consequences of acute versus chronic CDK12 loss in prostate carcinoma nominates distinct therapeutic strategies
2024 · Sander Frank, Thomas Persse, et al. · eLife · 4
PDF
Targeting advanced prostate cancer with STEAP1 chimeric antigen receptor T cell and tumor-localized IL-12 immunotherapy
2023 · V Bhatia, NV Kamat, et al. · immuneACCESS · 3
Integrative Surface Antigen Profiling of KLK2 and STEAP1 in Advanced Prostate Cancer
2026 · Erolcan Sayar, Helen M. Richards, et al. · Molecular Cancer Research · 1
Molecular consequences of acute versus chronic CDK12 loss in prostate carcinoma nominates distinct therapeutic strategies
2025 · Sander Frank, Thomas Persse, et al. · eLife · 1
Identifying prognostic targets in metastatic prostate cancer beyond AR
2025 · Emily Feng, Eric Feng, et al. · FEBS Open Bio · 1
PDF
Molecular consequences of acute versus chronic CDK12 loss in prostate carcinoma nominates distinct therapeutic strategies
2024 · Sander Frank, Thomas Persse, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1
Abstract 406: Characterizing the molecular features of the neuroendocrine phenotype in castration resistant prostate cancer.
2013 · Xiaotun Zhang, Ilsa Coleman, et al. · Cancer Research · 1
Differential Gene Expression in Normal Prostate Epithelium of Men With and Without Prostate Cancer: Evidence for a Prostate Cancer Field Effect
2008 · Michael C Risk, Ilsa Coleman, et al. · The Journal of Urology · 1
Deep learning–based histologic classifiers enable molecular subtyping of metastatic prostate cancer
2026 · Zhijun Chen, Erolcan Sayar, et al. · JCI Insight
PDF
798 mCRPC: From Morphology to Survival
2026 · Jeanne Maria Dsouza, Helen Richards, et al. · Laboratory Investigation
Abstract PR009: A dependency map of androgen receptor activity identifies drivers of prostate cancer growth
2026 · Arnab Bose, Ilsa Coleman, et al. · Cancer Research
Abstract PR005: Epigenetically Informed Therapeutic Strategies for DNA-Hypomethylated Prostate Cancer
2026 · Pallabi Mustafi, Helen Richards, et al. · Cancer Research
Abstract A073: Identification of a potential intermediate cell state in the treatment-induced lineage transition from AR-driven prostate cancer to neuroendocrine prostate cancer
2026 · Ruihong Wang, Dapei Li, et al. · Cancer Research
Abstract PR032: Therapeutic targeting of eIF4E cap-binding domain reveals control of lineage fate in prostate cancer
2026 · Rashmi Mishra, Sihyeon Song, et al. · Cancer Research
Abstract B022: LuCaP189.4_CL: a novel 2D model of AR - high, CDK12 - mutant mCRPC suitable for studies of genetic and therapeutic vulnerabilities
2026 · Sander Frank, Dapei Li, et al. · Cancer Research
Works count: 49
Citation count: 861
H-index: 9
I10-index: 9
Year
Topic
Type